162PD - Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification (TNBCtype-4)
| Autor: | Echavarria Diaz-Guardamino, I., Picornell, A.C., López-Tarruella, S., Jerez, Y., Hoadley, K., Alvarez, E., del Monte-Millán, M., Gayarre, J., Ramos-Medina, R., Massarrah, T., Ocaña, I., Cebollero, M., Moreno Antón, F., García-Saenz, J.A., Gomez Moreno, H., Fuentes, H., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Perou, C., Martin Jimenez, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v48-v48 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|